𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis

✍ Scribed by Dr. Douglas L. Arnold; Gerald T. Riess; Paul M. Matthews; Gordon S. Francis; D. Louis Collins; Christina Wolfson; Jack P. Antel

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
638 KB
Volume
36
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Guidelines for using quantitative magnet
Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis
✍ Mark A. Horsfield; Gareth J. Barker; Frederik Barkhof; David H. Miller; Alan J. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

## Abstract Quantitative evaluation of brain magnetic resonance imaging (MRI) scans is now an accepted part of the trial of new putative treatments for multiple sclerosis (MS). However, conventional MRI is not pathologically specific, and it does not reveal the details of the pathological processes

Use of proton nuclear magnetic resonance
Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease
✍ Shigeki Ono; Fuminori Moriyasu; Motoshige Nabeshima; Kozo Kajimura; Yukitaka Yam πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 707 KB

In 1986, narrow plasma proton nuclear magnetic resonance (NMR) methyl and methylene line widths were reported to be associated with malignant disease, but more recent studies have not confirmed this relationship. The authors analyzed 106 plasma samples from healthy control subjects and patients with